TradingView
KLang
Jul 16, 2015 2:03 AM

IBB 

iShares Biotechnology ETFNASDAQ

Description

Crab nearly completed. Candlestick makes me question if it will achieve target.
Comments
docwesley90
One thing I noticed about the IBB is that it corrected 10% unlike the overall market did. Short float is also 33%. GILD is also the heaviest weighted company within the IBB and it is trading very cheap to it's peers due to concern that profits may be limited to their current pipeline. If they acquire another company, which they probably will, GILD will soar taking IBB with it (Kind of like CELG did). I know this is a focus on technicals but may be something to consider :)
More